Duration of Vitrectomy and postoperative cataract in the Vitrectomy for Macular Hole Study

American Journal of Ophthalmology

Volumn 132, Issue 6, 2001, Pages 881-887

  Cheng, Lingyun ^a   Azen, Stanley P ^b   El Bradey, Mohamed H ^a   Scholz, Barbara M ^a   Chaidhawangul, Sunan ^a   Toyoguchi, Mitsuko ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LENS NUCLEUS; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA HOLE; RISK ASSESSMENT; RISK FACTOR; SCLEROSIS; SCORING SYSTEM; VITRECTOMY;

AGE FACTORS; AGED; BLOOD PRESSURE; CATARACT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LENS, CRYSTALLINE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REFRACTION, OCULAR; RETINAL PERFORATIONS; RISK FACTORS; SCLEROSIS; TIME FACTORS; VITRECTOMY;

EID: 0035209649     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)01263-6     Document Type: Article

References (15)

1. Margherio RR, Cox MS Jr, Trese MT, et al. Removal of epimacular membranes. Ophthalmology 1985;92:1075-1083.
2. de Bustros S, Thompson JT, Michels RG, et al. Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol 1988;105:160-164.
3. Cherfan GM, Michels RG, de Bustros S, et al. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol 1991;111:434-438.
4. Ogura Y, Takanashi T, Ishigooka H, Ogino N. Quantitative analysis of lens changes after vitrectomy by fluorophotometry. Am J Ophthalmol 1991;111:179-183.
5. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;119:48-54.
6. Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology 1995;102:1466-1471.
7. Kim JW, Freeman WR, el-Haig W, et al. Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group. Ophthalmology 1995;102:1818-1828.
8. Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 1997;115:11-21.
9. Cheng LY, Freeman WR, Ozerdem U, et al. Prevalence, correlates, and natural history of epiretinal membranes surrounding idiopathic macular holes. Ophthalmology 2000;107:853-859.
10. Chylack LT, Jr, Leske MC, McCarthy D, et al. Lens opacities classification system II (LOCS II). Arch Ophthalmol 1989;107:991-997.
11. Maraini G, Pasquini P, Tomba MC, et al. An independent evaluation of the Lens Opacities Classification System II (LOCS II). The Italian-American Cataract Study Group. Ophthalmology 1989;96:611-615.
12. Magno BV, Lasa SM. Senile cataract progression studies using the Lens Opacities Classification System II. Invest Ophthalmol Vis Sci 1993;34:2138-2141.
13. Poliner LS, Olk RJ, Grand MG, et al. Surgical management of premacular fibroplasia. Arch Ophthalmol 1988;106:761-764.
14. Mougharbel M, Koch FH, Boker T, Spitznas M. No cataract two years after pneumatic retinopexy. Ophthalmology 1994;101:1191-1194.
15. Thompson JT, Glaser BM, Sjaarda RN, et al. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-1200.